CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia.

CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia. J Clin Oncol. 2018 09 10; 36(26):2684-2692.

View in: PubMed

subject areas

Aged
Antineoplastic Combined Chemotherapy Protocols
Cytarabine
Daunorubicin
Female
Humans
Leukemia, Myeloid, Acute
Male
Middle Aged
Neoplasms, Second Primary

authors with profiles

Robert K. Stuart